Results 281 to 290 of about 3,448,511 (303)
Some of the next articles are maybe not open access.
Extended spectrum beta-lactamases: a therapeutic dilemma
The Pediatric Infectious Disease Journal, 2002openaire +2 more sources
Extended-spectrum plasmid-mediated beta-lactamases.
The Journal of antimicrobial chemotherapy, 1996Extended-spectrum beta-lactamases (ESBLs) are mutant enzymes which derive from TEM or SHV (class A) enzymes. They confer variable levels of resistance to cefotaxime, ceftazidime and other broad-spectrum cephalosporins and to monobactams such as aztreonam but have no detectable activity against cephamycins and carbapenems. Recently, new plasmid-mediated
openaire +1 more source
Extended-Spectrum Beta-Lactamases
Seminars in Respiratory and Critical Care Medicine, 2003Jan E Patterson
exaly
Replicon typing of plasmids in Escherichia coli producing extended-spectrum beta-lactamases.
Journal of Antimicrobial Chemotherapy, 2009G. Marcade +7 more
semanticscholar +1 more source
What's new in antibiotic resistance? Focus on beta-lactamases
Drug Resistance Updates, 2006Robert A Bonomo, Andrea M Hujer
exaly
Influence of capsule and extended-spectrum beta-lactamases encoding plasmids upon adhesion
Research in Microbiology, 2007Christiane Forestier
exaly

